Myxoma laboratory tests: Difference between revisions
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with cardiac myxoma include [[anemia]], [[leukocytosis]] and elevated [[erythrocyte sedimentation rate]]. However, these results are generally non-diagnostic. | Laboratory findings consistent with cardiac myxoma include [[anemia]], [[leukocytosis]] and elevated [[erythrocyte sedimentation rate]]. However, these results are generally non-diagnostic.<ref name="pmid7477198">{{cite journal |vauthors=Reynen K |title=Cardiac myxomas |journal=N. Engl. J. Med. |volume=333 |issue=24 |pages=1610–7 |year=1995 |pmid=7477198 |doi=10.1056/NEJM199512143332407 |url=}}</ref> | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Revision as of 18:55, 30 November 2015
|
Myxoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myxoma laboratory tests On the Web |
|
American Roentgen Ray Society Images of Myxoma laboratory tests |
|
Risk calculators and risk factors for Myxoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]Maria Fernanda Villarreal, M.D. [3]
Overview
Laboratory findings consistent with cardiac myxoma include anemia, leukocytosis and elevated erythrocyte sedimentation rate. However, these results are generally non-diagnostic.[1]
Laboratory Findings
The clinical utility of laboratory tests in the diagnosis of cardiac myxoma remains nonspecific.[1] Laboratory findings consistent with cardiac myxoma include anemia, leukocytosis and elevated erythrocyte sedimentation rate.
Blood tests
There is no specific blood test for the diagnosis of cardiac myxoma. However, constitutional symptoms are associated with the following blood count (CBC) findings:[2]
- Anemia - Normochromic or hypochromic.
- Leukocytosis
- Elevated erythrocyte sedimentation rate(ESR)
- Elevated C-reactive protein
- Serum globulin level (Hypergammaglobulinemia) a1-globulin serum levels can be found in patients with cardiac myxoma, and have been proposed as predictive markers of embolic accidents. [3]
- Serum IL-6 - Atrial myxoma cells are capable of producing IL-6. Consequently, IL-6 is used as a marker of recurrence in cardiac myxomas.[4]
References
- ↑ 1.0 1.1 Reynen K (1995). "Cardiac myxomas". N. Engl. J. Med. 333 (24): 1610–7. doi:10.1056/NEJM199512143332407. PMID 7477198.
- ↑ Hartig I, Kraatz EG, Beurich HW, Moosig F (2014). "[Atrial myxoma with clinical signs of systemic inflammatory disease.]". Z Rheumatol. doi:10.1007/s00393-013-1347-y. PMID 24599357.
- ↑ Jelic J, Milicić D, Alfirević I, Anić D, Baudoin Z, Bulat C, Corić V, Dadić D, Husar J, Ivanćan V, Korda Z, Letica D, Predrijevac M, Ugljen R, Vućemilo I (1996). "Cardiac myxoma: diagnostic approach, surgical treatment and follow-up. A twenty years experience". J Cardiovasc Surg (Torino). 37 (6 Suppl 1): 113–7. PMID 10064362.
- ↑ Ezerioha N, Feng W (2015). "Intracardiac Myxoma, Cerebral Aneurysms and Elevated Interleukin-6". Case Rep Neurol. 7 (2): 152–5. doi:10.1159/000437256. PMC 4560324. PMID 26351445.